FDA Approves Enhertu for Early-Stage Breast Cancer

The FDA just approved Enhertu for early-stage HER2-positive breast cancer, giving patients a powerful new treatment option before cancer spreads.

This marks a major step forward in catching and treating breast cancer when it's most beatable.